Skip to main content
Journal ArticleOPEN ACCESS

It Is Time to Consider Glucagon-Like Peptide-1 Receptor Agonists for the Treatment of Type 2 Diabetes in Youth

Frontiers in Endocrinology (2019) 10
DOI: 10.3389/fendo.2019.00738
5Citations
Citations of this article
19Readers
Mendeley users who have this article in their library.

Author supplied keywords

Cite

CITATION STYLE

APA

Oberle, M. M., & Kelly, A. S. (2019). It Is Time to Consider Glucagon-Like Peptide-1 Receptor Agonists for the Treatment of Type 2 Diabetes in Youth. Frontiers in Endocrinology, 10. https://doi.org/10.3389/fendo.2019.00738

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free